Recent Press Releases

THERAMetrics holding AG (SIX: TMX) and its fully owned subsidiary, Pierrel Research International AG (PRINT), announce €5 Million New Business (Contracts) signed in December 2013

Stans, Switzerland, December 18, 2013 - Ms Maxime Stevens, Group CEO of Pierrel Research International AG announces that, as anticipated in our press release of December 9th, 2013, an additional...

Roche and Genentech Acquire Unlimited Access to Open Monoclonal Technology's OmniRat®

December 18, 2013 09:00 AM Eastern Standard Time PALO ALTO, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic...

Pay Incentives Lower in Clinical Research Organizations Than in General Industry; Employee Turnover Remains High in the U.S. and is Over 30 Percent in Some Countries

Employees at clinical research organizations (CROs) receive lower annual and long term incentives than their counterparts in other industries, according to the 15th annual CRO Industry Global...

Algorithme Pharma Gains Key Patient Access Through Partnership with Hôpital Maisonneuve-Rosemont (HMR)

Algorithme Pharma, a leading early stage clinical research organization, is pleased to offer sponsors increased patient access in key therapeutic areas through the strategic partnership with...

CROS NT Ltd Announces Appointment of Andrew MacGarvey as CEO

LONDON -- As part of the CROS NT Group global strategy, the company today announced the appointment of Andrew MacGarvey to the role of Chief Executive Officer and President from 1st January 2014. The...

Charles River Laboratories Announces Organizational Changes to Enhance Global Capabilities

WILMINGTON, Mass.-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced organizational changes which are designed to continue to improve the Company's operating efficiency...

Bayer HealthCare Announces Collaboration with the University of Texas MD Anderson Cancer Center

Clinical programs and collaborations in oncology to be jointly performed over three years WHIPPANY, N.J. -- Bayer HealthCare announced today that the company has signed a master agreement for the...

genae Opens Offices in Switzerland

ANTWERP, Belgium and ZÜRICH -- genae, a global Contract Research Organization (CRO) and services provider for the medical devices industries, today announced the incorporation of genae...

THERAMETRICS HOLDING AG (SIX: TMX) RECOGNISES IMPROVED MARKET RECOGNITION AND SUPPORT OF ITS FULLY OWNED SUBSIDIARY, PIERREL RESEARCH INTERNATIONAL AG (PRINT), AND NOMINATION OF MS MAXIME STEVENS AS PRINT BOARD MEMBER

Stans, Switzerland, December 9, 2013 - Ms Maxime Stevens joined PRINT as CBDO (Chief Business Development Officer) in April 2013, tasked with the responsibility of strategically restructuring and...

Bridgepoint Development Capital to acquire Quotient Clinical

Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development...

Oxygen Biotherapeutics Selects Duke Clinical Research Institute to Conduct Phase 3 Trial of Levosimendan

Oxygen Biotherapeutics Selects Duke Clinical Research Institute to Conduct Phase 3 Trial of Levosimendan Phase 3 trials anticipated to begin in Q3 2014 and to be conducted at 50 major cardiac...

Hiroharu Okochi Named New President of Harlan Japan

Hiroharu Okochi Named New President of Harlan Japan (Itingen, Switzerland; Dec. 10, 2013)Harlan has recently announced Hiroharu Okochi as president of Harlan Japan. Okochi will have full...

Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal

Pfizer Inc. (NYSE: PFE) today announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials. The...

Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors

WILMINGTON, Mass.-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Craig B. Thompson, M.D., President and Chief Executive Officer, Memorial...

Venn Life Sciences Holdings Plc ("Venn" or the "Company") Acquisition of Belfast based CRO

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device...

Agilux Laboratories Announces Space Expansion to Support Increasing Demand for Its In Vivo Pharmacokinetics Services

WORCESTER, Mass.--Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced today that it has undergone a...

SARAH CANNON RESEARCH INSTITUTE ANNOUNCES ACQUISITION OF CLINICAL DEVELOPMENT GROUP

NASHVILLE, TN – Sarah Cannon Research Institute (SCRI) announced today the acquisition of Clinical Development Group (CDG), a strategic clinical trial consulting firm based in New Haven, CT. By...

inVentiv Health Hires Senior Life Sciences Executive to Oversee Expansion of Multi-faceted Operations in India

BURLINGTON, Mass.-- inVentiv Health, offering best-in-class clinical, commercial and consulting services to the biopharmaceutical industry, has named a senior executive in India's life sciences...

Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer

REDWOOD CITY, Calif. and CRAIGAVON, United Kingdom -- Genomic Health, Inc. (Nasdaq:GHDX) and ALMAC GROUP Ltd jointly announced today that Genomic Health will exclusively license Almac Group's...

Aptuit Names Jonathan Goldman As CEO

GREENWICH, Conn., Dec. 2, 2013 -- Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company's...